✓Strengths
- Low debt: debt-to-equity of 0.13.
- Comfortable interest cover: operating profit covers interest about 421.3 times.
- Return on equity is healthy at 19.4%.
- Return on capital employed is healthy at 18.3%.
- Net profit margin is strong at 48.3%.
- Current assets comfortably cover current liabilities (current ratio 11.38).
- Profit has compounded about 204% a year over five years.
- Sales have compounded about 36% a year over five years.
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.09
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreModerate
4 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 4,074.16
ROCE18.27%
ROE19.38%
Debt to Equity0.13
Current Ratio11.38
EPS₩ 789.00
PAT Margin48.30%
ICR421.25
Compounded Sales Growth
10 Years
—
5 Years
36.24%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
204.19%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
19.38%